Puma Biotechnology, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Los Angeles, CA
PBYI chart
What traders are saying about $PBYI
Latest postsPuma Biotechnology, Inc. news
- Puma Biotechnology, Inc. 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:PBYI) 2026-11-10
Seeking Alpha ·
- Puma Biotechnology 3Q 2026: Revenue $55.06M, EPS $0.11 — 10-Q Summary
TradingView ·
- Puma: 3 Key Takeaways for Long-Term Investors
fool.com ·
- Puma Biotechnology Inc (PBYI) (Q3 2026) Earnings Call Highlights: Debt-Free and Raising ...
Yahoo Finance ·
- Puma Biotechnology (PBYI) Q3 2026 Earnings Call Transcript
fool.com ·
- Puma Biotechnology, Inc. Q3 2026 Earnings Call Summary
app.moby.co ·
- Puma Biotechnology Q3 Earnings Call Highlights
marketbeat.com ·
- Puma Biotech (PBYI) Tops Q3 Earnings Estimates
Yahoo Finance ·
- Puma Biotechnology earnings beat by $0.06, revenue fell short of estimates
Investing.com UK ·
- Puma Biotech: Q3 Earnings Snapshot
Yahoo Finance ·
- Puma Biotechnology Q3 2026 Earnings Call Transcript
Benzinga ·
- Puma Biotechnology Q3 product revenue rises on increased NERLYNX demand
TradingView ·
Puma Biotechnology, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $228.4M | $230.5M | $235.6M | $228.0M |
| Net income | $31.1M | $30.3M | $21.6M | $2,000 |
| Diluted EPS | $0.61 | $0.62 | $0.45 | $0.00 |
| Total assets (year end) | $216.3M | $213.3M | $230.5M | $222.1M |
| Cash and equivalents (year end) | $29.6M | $69.2M | $84.6M | $76.2M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Puma Biotechnology, Inc.
- Ticker
- PBYI (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Los Angeles, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1401667
- Former names
- INNOVATIVE ACQUISITIONS CORP
Frequently asked questions
What exchange is Puma Biotechnology, Inc. listed on?
Puma Biotechnology, Inc. trades on the Nasdaq under the ticker symbol PBYI.
What industry is Puma Biotechnology, Inc. in?
Puma Biotechnology, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Puma Biotechnology, Inc. headquartered?
Puma Biotechnology, Inc.'s business address on file with the SEC is in Los Angeles, CA.
When does Puma Biotechnology, Inc.'s fiscal year end?
Puma Biotechnology, Inc.'s fiscal year ends on December 31.
How much revenue did Puma Biotechnology, Inc. report?
Puma Biotechnology, Inc. reported $228.4M in revenue for calendar year 2025, according to its SEC filings.